Patients with substance use disorder: know your rights
An informational flyer explaining the rights of patients with substance use disorder, including opioid use disorder (OUD), and protections against discrimination in health care.
An informational flyer explaining the rights of patients with substance use disorder, including opioid use disorder (OUD), and protections against discrimination in health care.
Overview of ScalaNW processes for hospitals providing MOUD (sometimes called MAT) and follow-up care.
Overview of ScalaNW processes for follow-up clinics, including bridge clinics and outpatient MOUD/MAT care.
Dr. Buchholz, MD applies knowledge learned in parts 1 and 2 to clinical cases, highlighting key considerations for initiation of MOUD (sometimes called MAT).
Dr. Buchholz, MD reviews FDA-approved medications for opioid use disorder, including buprenorphine, methadone, and naltrexone, plus initiation strategies across treatment settings.
Heidi Bray, DNP, talks about the importance of access to MOUD (sometimes called Medication for Addiction Treatment, or MAT).
Dr. Amy Burns talks about reducing stigma associated with MOUD (sometimes called Medication for Addiction Treatment, or MAT).
Dr. Gillian Zuckerman talks about how MOUD (sometimes called Medication for Addiction Treatment, or MAT) helps people heal and rebuild.
Fire captain Keith Sharp talks about how MOUD (sometimes called Medication for Addiction Treatment, or MAT) helps him serve his community.
A quick guide to how buprenorphine works, when to start treatment, and how to avoid precipitated withdrawal during induction.